Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline - PubMed (original) (raw)
Practice Guideline
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline
Paul E Stevens et al. Ann Intern Med. 2013.
Free article
Abstract
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed clinical practice guidelines in 2012 to provide guidance on the evaluation, management, and treatment of chronic kidney disease (CKD) in adults and children who are not receiving renal replacement therapy.
Methods: The KDIGO CKD Guideline Development Work Group defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence that had been summarized by an evidence review team. Searches of the English-language literature were conducted through November 2012. Final modification of the guidelines was informed by the KDIGO Board of Directors and a public review process involving registered stakeholders.
Recommendations: The full guideline included 110 recommendations. This synopsis focuses on 10 key recommendations pertinent to definition, classification, monitoring, and management of CKD in adults.
Similar articles
- Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.
Tonelli M, Wanner C; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. Tonelli M, et al. Ann Intern Med. 2014 Feb 4;160(3):182. doi: 10.7326/M13-2453. Ann Intern Med. 2014. PMID: 24323134 - KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. Inker LA, et al. Am J Kidney Dis. 2014 May;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16. Am J Kidney Dis. 2014. PMID: 24647050 Review. - Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Gordon CE, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Earley A, Di M, Cheung M, Jadoul M, Martin P. Gordon CE, et al. Ann Intern Med. 2019 Oct 1;171(7):496-504. doi: 10.7326/M19-1539. Epub 2019 Sep 24. Ann Intern Med. 2019. PMID: 31546256 - KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Sarnak MJ, Bloom R, Muntner P, Rahman M, Saland JM, Wilson PW, Fried L. Sarnak MJ, et al. Am J Kidney Dis. 2015 Mar;65(3):354-66. doi: 10.1053/j.ajkd.2014.10.005. Epub 2014 Nov 18. Am J Kidney Dis. 2015. PMID: 25465166 Review. - Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.
Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K. Navaneethan SD, et al. Ann Intern Med. 2021 Mar;174(3):385-394. doi: 10.7326/M20-5938. Epub 2020 Nov 10. Ann Intern Med. 2021. PMID: 33166222
Cited by
- Effect of tibial cortex transverse transport in patients with recalcitrant diabetic foot ulcers: A prospective multicenter cohort study.
Chen Y, Ding X, Zhu Y, Jia Z, Qi Y, Chen M, Lu J, Kuang X, Zhou J, Su Y, Zhao Y, Lu W, Zhao J, Hua Q. Chen Y, et al. J Orthop Translat. 2022 Oct 12;36:194-204. doi: 10.1016/j.jot.2022.09.002. eCollection 2022 Sep. J Orthop Translat. 2022. PMID: 36263383 Free PMC article. - Comparison of three creatinine-based equations to predict adverse outcome in a cardiovascular high-risk cohort: an investigation using the SPRINT research materials.
Emrich IE, Pickering JW, Götzinger F, Kramann R, Kunz M, Lauder L, Papademetriou V, Böhm M, Heine GH, Mahfoud F. Emrich IE, et al. Clin Kidney J. 2024 Jan 19;17(2):sfae011. doi: 10.1093/ckj/sfae011. eCollection 2024 Feb. Clin Kidney J. 2024. PMID: 38313686 Free PMC article. - Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetes.
Wang Y, Chen H. Wang Y, et al. Hormones (Athens). 2024 Sep 4. doi: 10.1007/s42000-024-00593-4. Online ahead of print. Hormones (Athens). 2024. PMID: 39230795 - TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review.
Zixin Y, Lulu C, Xiangchang Z, Qing F, Binjie Z, Chunyang L, Tai R, Dongsheng O. Zixin Y, et al. Front Pharmacol. 2022 Aug 12;13:929262. doi: 10.3389/fphar.2022.929262. eCollection 2022. Front Pharmacol. 2022. PMID: 36034781 Free PMC article. Review. - Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.
Li L, Li X, Xia Y, Chu Y, Zhong H, Li J, Liang P, Bu Y, Zhao R, Liao Y, Yang P, Lu X, Jiang S. Li L, et al. Front Pharmacol. 2020 May 29;11:786. doi: 10.3389/fphar.2020.00786. eCollection 2020. Front Pharmacol. 2020. PMID: 32547394 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical